A Long-Acting Formulation of the Integrase Inhibitor Raltegravir Protects Humanized BLT Mice From Repeated High-Dose Vaginal HIV Challenges
Journal of Antimicrobial Chemotherapy - United Kingdom
doi 10.1093/jac/dkw042
Full Text
Open PDFAbstract
Available in full text
Date
March 21, 2016
Authors
Publisher
Oxford University Press (OUP)